Follow
T Panaretakis
T Panaretakis
Unknown affiliation
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
107352021
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
53242018
Calreticulin exposure dictates the immunogenicity of cancer cell death
M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ...
Nature medicine 13 (1), 54-61, 2007
32242007
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ...
Nature medicine 15 (10), 1170-1178, 2009
20252009
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
11462015
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
T Panaretakis, O Kepp, U Brockmeier, A Tesniere, AC Bjorklund, ...
The EMBO journal 28 (5), 578-590, 2009
9052009
Consensus guidelines for the detection of immunogenic cell death
O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ...
Oncoimmunology 3 (9), e955691, 2014
8332014
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M Obeid, T Panaretakis, N Joza, R Tufi, A Tesniere, P Van Endert, ...
Cell Death & Differentiation 14 (10), 1848-1850, 2007
5552007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, L Apetoh, F Ghiringhelli, L Zitvogel, ...
Cell Death & Differentiation 15 (1), 3-12, 2008
5412008
Tumor cell-derived exosomes: a message in a bottle
P Kharaziha, S Ceder, Q Li, T Panaretakis
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (1), 103-111, 2012
4272012
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
T Panaretakis, N Joza, N Modjtahedi, A Tesniere, I Vitale, M Durchschlag, ...
Cell Death & Differentiation 15 (9), 1499-1509, 2008
4082008
Immunogenic cancer cell death: a key-lock paradigm
A Tesniere, L Apetoh, F Ghiringhelli, N Joza, T Panaretakis, O Kepp, ...
Current opinion in immunology 20 (5), 504-511, 2008
3592008
A novel community driven software for functional enrichment analysis of extracellular vesicles data
M Pathan, S Keerthikumar, D Chisanga, R Alessandro, CS Ang, ...
Journal of extracellular vesicles 6 (1), 1321455, 2017
3422017
Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA
M Berndtsson, M Hägg, T Panaretakis, AM Havelka, MC Shoshan, ...
International journal of cancer 120 (1), 175-180, 2007
2802007
Ecto‐calreticulin in immunogenic chemotherapy
M Obeid, A Tesniere, T Panaretakis, R Tufi, N Joza, P Van Endert, ...
Immunological reviews 220 (1), 22-34, 2007
2522007
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy
E Laane, KP Tamm, E Buentke, K Ito, P Khahariza, J Oscarsson, ...
Cell Death & Differentiation 16 (7), 1018-1029, 2009
2442009
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from “silent” to immunogenic
M Obeid, T Panaretakis, A Tesniere, N Joza, R Tufi, L Apetoh, ...
Cancer research 67 (17), 7941-7944, 2007
2022007
Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin
T Panaretakis, K Pokrovskaja, MC Shoshan, D Grandér
Journal of Biological Chemistry 277 (46), 44317-44326, 2002
1922002
Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen …
T Panaretakis, IG Shabalina, D Grandér, MC Shoshan, JW DePierre
Toxicology and applied pharmacology 173 (1), 56-64, 2001
1792001
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
V Atsaves, N Tsesmetzis, D Chioureas, L Kis, V Leventaki, E Drakos, ...
Leukemia 31 (7), 1633-1637, 2017
1692017
The system can't perform the operation now. Try again later.
Articles 1–20